TLDR Deucravacitinib helped a man regrow hair significantly.
A 51-year-old man with alopecia universalis (AU) and psoriasis vulgaris experienced significant hair regrowth during treatment with deucravacitinib, a tyrosine kinase-2 inhibitor. Initially, the patient had almost complete hair loss and a high Severity of Alopecia Tool Score (SALT score) of 97. After 7 months of deucravacitinib therapy, his SALT score improved to 13, with substantial regrowth of scalp, eyebrow, and body hair, and no adverse events reported. This case suggests that deucravacitinib may be effective for AU, although further controlled studies are needed to confirm its efficacy. The improvement in psoriasis was also noted, with the Psoriasis Area and Severity Index (PASI) decreasing from 8 to 4. The study highlights the potential of deucravacitinib as a treatment option for severe forms of alopecia areata.
19 citations
,
August 2023 in “Journal of Dermatological Treatment” Abrocitinib may effectively treat stubborn alopecia universalis.
January 2023 in “Indian Dermatology Online Journal” No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.
1 citations
,
January 2023 in “SAGE open medical case reports” A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.
1 citations
,
August 2023 in “Acta dermato-venereologica” Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.
6 citations
,
November 2022 in “Journal of autoimmunity” JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.
October 2022 in “Journal of Armed Forces Medical College, Bangladesh” Tofacitinib is effective and safe for treating alopecia areata.
148 citations
,
December 2018 in “Journal of autoimmunity” Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.
39 citations
,
April 2016 in “Case Reports in Dermatology” Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.
5 citations
,
June 2015 in “Veterinary dermatology” A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.
31 citations
,
January 1981 PUVA-therapy is not very effective for severe hair loss types like alopecia totalis or universalis.